174 related articles for article (PubMed ID: 19452524)
1. Tumor markers and rectal cancer: support for an inflammation-related pathway.
Slattery ML; Wolff RK; Herrick J; Caan BJ; Samowitz W
Int J Cancer; 2009 Oct; 125(7):1698-704. PubMed ID: 19452524
[TBL] [Abstract][Full Text] [Related]
2. Alcohol consumption and rectal tumor mutations and epigenetic changes.
Slattery ML; Wolff RK; Herrick JS; Curtin K; Caan BJ; Samowitz W
Dis Colon Rectum; 2010 Aug; 53(8):1182-9. PubMed ID: 20628283
[TBL] [Abstract][Full Text] [Related]
3. Somatic alterations, metabolizing genes and smoking in rectal cancer.
Curtin K; Samowitz WS; Wolff RK; Herrick J; Caan BJ; Slattery ML
Int J Cancer; 2009 Jul; 125(1):158-64. PubMed ID: 19358278
[TBL] [Abstract][Full Text] [Related]
4. PPARgamma and colon and rectal cancer: associations with specific tumor mutations, aspirin, ibuprofen and insulin-related genes (United States).
Slattery ML; Curtin K; Wolff R; Ma KN; Sweeney C; Murtaugh M; Potter JD; Levin TR; Samowitz W
Cancer Causes Control; 2006 Apr; 17(3):239-49. PubMed ID: 16489531
[TBL] [Abstract][Full Text] [Related]
5. Nutrients in folate-mediated, one-carbon metabolism and the risk of rectal tumors in men and women.
Curtin K; Samowitz WS; Ulrich CM; Wolff RK; Herrick JS; Caan BJ; Slattery ML
Nutr Cancer; 2011; 63(3):357-66. PubMed ID: 21462086
[TBL] [Abstract][Full Text] [Related]
6. Calcium, vitamin D, VDR genotypes, and epigenetic and genetic changes in rectal tumors.
Slattery ML; Wolff RK; Herrick JS; Caan BJ; Samowitz W
Nutr Cancer; 2010; 62(4):436-42. PubMed ID: 20432164
[TBL] [Abstract][Full Text] [Related]
7. Microsatellite instability and survival in rectal cancer.
Samowitz WS; Curtin K; Wolff RK; Tripp SR; Caan BJ; Slattery ML
Cancer Causes Control; 2009 Nov; 20(9):1763-8. PubMed ID: 19669908
[TBL] [Abstract][Full Text] [Related]
8. Assessing tumor mutations to gain insight into base excision repair sequence polymorphisms and smoking in colon cancer.
Curtin K; Samowitz WS; Wolff RK; Ulrich CM; Caan BJ; Potter JD; Slattery ML
Cancer Epidemiol Biomarkers Prev; 2009 Dec; 18(12):3384-8. PubMed ID: 19959686
[TBL] [Abstract][Full Text] [Related]
9. Colon tumor mutations and epigenetic changes associated with genetic polymorphism: insight into disease pathways.
Slattery ML; Wolff RK; Curtin K; Fitzpatrick F; Herrick J; Potter JD; Caan BJ; Samowitz WS
Mutat Res; 2009 Jan; 660(1-2):12-21. PubMed ID: 18992263
[TBL] [Abstract][Full Text] [Related]
10. IL6 genotypes and colon and rectal cancer.
Slattery ML; Wolff RK; Herrick JS; Caan BJ; Potter JD
Cancer Causes Control; 2007 Dec; 18(10):1095-105. PubMed ID: 17694420
[TBL] [Abstract][Full Text] [Related]
11. Antioxidants, carotenoids, and risk of rectal cancer.
Murtaugh MA; Ma KN; Benson J; Curtin K; Caan B; Slattery ML
Am J Epidemiol; 2004 Jan; 159(1):32-41. PubMed ID: 14693657
[TBL] [Abstract][Full Text] [Related]
12. Diet, physical activity, and body size associations with rectal tumor mutations and epigenetic changes.
Slattery ML; Curtin K; Wolff RK; Herrick JS; Caan BJ; Samowitz W
Cancer Causes Control; 2010 Aug; 21(8):1237-45. PubMed ID: 20383576
[TBL] [Abstract][Full Text] [Related]
13. KRAS mutations and CDKN2A promoter methylation show an interactive adverse effect on survival and predict recurrence of rectal cancer.
Kohonen-Corish MR; Tseung J; Chan C; Currey N; Dent OF; Clarke S; Bokey L; Chapuis PH
Int J Cancer; 2014 Jun; 134(12):2820-8. PubMed ID: 24259266
[TBL] [Abstract][Full Text] [Related]
14. Rectal cancer profiling identifies distinct subtypes in India based on age at onset, genetic, epigenetic and clinicopathological characteristics.
Laskar RS; Ghosh SK; Talukdar FR
Mol Carcinog; 2015 Dec; 54(12):1786-95. PubMed ID: 25418895
[TBL] [Abstract][Full Text] [Related]
15. Polymorphisms in insulin-related genes predispose to specific KRAS2 and TP53 mutations in colon cancer.
Samowitz WS; Wolff RK; Ma KN; Andersen K; Caan B; Slattery ML
Mutat Res; 2006 Mar; 595(1-2):117-24. PubMed ID: 16448675
[TBL] [Abstract][Full Text] [Related]
16. Mutations in specific codons of the KRAS oncogene are associated with variable resistance to neoadjuvant chemoradiation therapy in patients with rectal adenocarcinoma.
Duldulao MP; Lee W; Nelson RA; Li W; Chen Z; Kim J; Garcia-Aguilar J
Ann Surg Oncol; 2013 Jul; 20(7):2166-71. PubMed ID: 23456389
[TBL] [Abstract][Full Text] [Related]
17. A comparison of colon and rectal somatic DNA alterations.
Slattery ML; Curtin K; Wolff RK; Boucher KM; Sweeney C; Edwards S; Caan BJ; Samowitz W
Dis Colon Rectum; 2009 Jul; 52(7):1304-11. PubMed ID: 19571709
[TBL] [Abstract][Full Text] [Related]
18. Down-regulation of p21 (CDKN1A/CIP1) is inversely associated with microsatellite instability and CpG island methylator phenotype (CIMP) in colorectal cancer.
Ogino S; Kawasaki T; Kirkner GJ; Ogawa A; Dorfman I; Loda M; Fuchs CS
J Pathol; 2006 Oct; 210(2):147-54. PubMed ID: 16850502
[TBL] [Abstract][Full Text] [Related]
19. Relative role of methylator and tumor suppressor pathways in ulcerative colitis-associated colon cancer.
Sanchez JA; Dejulius KL; Bronner M; Church JM; Kalady MF
Inflamm Bowel Dis; 2011 Sep; 17(9):1966-70. PubMed ID: 21618350
[TBL] [Abstract][Full Text] [Related]
20. CpG island methylator phenotype in colorectal cancers: comparison of the new and classic CpG island methylator phenotype marker panels.
Lee S; Cho NY; Yoo EJ; Kim JH; Kang GH
Arch Pathol Lab Med; 2008 Oct; 132(10):1657-65. PubMed ID: 18834226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
